Lifecore Biomedical Stock Analysis

Lifecore Stock Analysis Notes

About 74.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 0.56. Lifecore Biomedical had not issued any dividends in recent years. To find out more about Lifecore Biomedical contact James Hall at (952) 368-4300 or learn more at https://www.lifecore.com.

Lifecore Biomedical Investment Alerts

Lifecore Biomedical Upcoming and Recent Events

Lifecore Largest EPS Surprises

View All Earnings Estimates

Lifecore Biomedical Environmental, Social, and Governance (ESG) Scores

Lifecore Stock Institutional Investors

Note, although Lifecore Biomedical's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Lifecore Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 244.37 M.

Lifecore Profitablity

The company has Profit Margin (PM) of (0.11) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.05) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.05.

Management Efficiency

Lifecore Biomedical has return on total asset (ROA) of (0.0247) % which means that it has lost $0.0247 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2958) %, meaning that it created substantial loss on money invested by shareholders. Lifecore Biomedical's management efficiency ratios could be used to measure how well Lifecore Biomedical manages its routine affairs as well as how well it operates its assets and liabilities. As of 03/24/2025, Return On Tangible Assets is likely to drop to -0.02. In addition to that, Return On Capital Employed is likely to drop to 0.01. At this time, Lifecore Biomedical's Non Currrent Assets Other are relatively stable compared to the past year. As of 03/24/2025, Other Assets is likely to grow to about 25.1 M, while Total Assets are likely to drop slightly above 248.7 M.

Technical Drivers

As of the 24th of March, Lifecore Biomedical secures the Mean Deviation of 2.8, risk adjusted performance of (0.03), and Standard Deviation of 4.11. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Lifecore Biomedical, as well as the relationship between them. Please verify Lifecore Biomedical coefficient of variation and maximum drawdown to decide if Lifecore Biomedical is priced some-what accurately, providing market reflects its recent price of 6.6 per share. Given that Lifecore Biomedical has information ratio of (0.03), we recommend you to check Lifecore Biomedical's last-minute market performance to make sure the company can sustain itself at a future point.

Lifecore Biomedical Price Movement Analysis

Lifecore Biomedical Insider Trading Activities

Lifecore Biomedical Predictive Daily Indicators

Lifecore Biomedical Corporate Filings

Lifecore Biomedical Forecast Models

Lifecore Biomedical's time-series forecasting models are one of many Lifecore Biomedical's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Lifecore Biomedical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Lifecore Biomedical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Lifecore shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Lifecore Biomedical. By using and applying Lifecore Stock analysis, traders can create a robust methodology for identifying Lifecore entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Lifecore analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Lifecore analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Lifecore Biomedical stock analysis indicators help investors evaluate how Lifecore Biomedical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Lifecore Biomedical shares will generate the highest return on investment. By understating and applying Lifecore Biomedical stock analysis, traders can identify Lifecore Biomedical position entry and exit signals to maximize returns.

When running Lifecore Biomedical's price analysis, check to measure Lifecore Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lifecore Biomedical is operating at the current time. Most of Lifecore Biomedical's value examination focuses on studying past and present price action to predict the probability of Lifecore Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lifecore Biomedical's price. Additionally, you may evaluate how the addition of Lifecore Biomedical to your portfolios can decrease your overall portfolio volatility.